tiprankstipranks
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
US Market

Neurosense Therapeutics Ltd. (NRSN) Income Statement

Compare
130 Followers

Neurosense Therapeutics Ltd. Income Statement

Last quarter (Q1 2024), Neurosense Therapeutics Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Neurosense Therapeutics Ltd.'s net income was $-5.40M. See Neurosense Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -97.00K$ -89.00K--$ 0.00
Operating Expenses
$ 10.29M$ 13.55M$ 5.59M$ 2.89M$ 1.24M
Depreciation and Amortization
$ 97.00K$ 89.00K--$ 1.24M
EBITDA
$ -10.63M$ -13.38M$ -2.88M$ -2.83M$ -1.25M
Operating Income
$ -12.05M$ -13.55M$ -5.59M$ -2.89M$ -1.24M
Other Income/Expenses
$ 769.00K$ 1.21M$ 1.55M$ 60.00K$ 13.00K
Pretax Income
$ -11.28M$ -12.34M$ -4.04M$ -2.83M$ -1.22M
Net Income
$ -10.11M$ -11.20M$ -2.50M$ -2.83M$ -1.23M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.83$ -0.97$ -1.29$ -1.46$ -0.63
Diluted EPS
$ -0.83$ -0.97$ -1.29$ -1.46$ -0.63
Weighted Average Shares Outstanding
13.64M 11.50M 1.94M 1.94M 1.94M
Weighted Average Shares Outstanding (Diluted)
13.64M 11.50M 1.94M 1.94M 1.94M
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis